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Abstract
Background: In men, hypovitaminosis D as well as high and low testosterone levels have been linked to 
adverse events, including death. A biological interaction has been previously suggested between vitamin D 
and androgens. In a cohort study using Third National Health and Nutrition Examination Survey data, we 
simultaneously investigated circulating vitamin D and biomarkers of sex steroid hormones as predictors of 
all-cause mortality.
Methods: Age-adjusted and fully-adjusted Cox regression models were constructed to estimate hazard 
ratios (HR) and their 95% confidence intervals (CI). Whereas the vitamin D sufficient group (25(OH)D3≥30 
ng/ml) was selected as a referent, biomarkers of sex steroid hormones (testosterone, estradiol, SHBG) were 
defined as Loge-transformed continuous variables.
Results: Of 1,472 men with a mean age of 42.1 years at baseline, 382 died over a median of 192 months 
of follow-up. Estradiol levels were significantly higher among vitamin D deficient compared to vitamin 
D sufficient men and sex hormone binding globulin level was significantly higher in vitamin D sufficient 
compared to vitamin D insufficient or deficient groups. An inverse non-linear relationship was observed 
between all-cause mortality rate and levels of testosterone, estradiol and vitamin D, in fully-adjusted 
models. There were no significant interaction effects between vitamin D and sex steroid hormones in 
relation to all-cause mortality rate. 
Conclusions: Vitamin D and sex steroid hormones, but not sex hormone binding globulin, may be inversely 
and non-linearly related to all-cause mortality among adult men, after adjustment for baseline demographic, 
socioeconomic, lifestyle and clinical characteristics.
Keywords: All-cause mortality, androgens; cohort study, estradiol, sex hormone binding globulin, 
testosterone, vitamin D
© 2015 Beydoun et al; licensee Herbert Publications Ltd. This is an Open Access article distributed under the terms of Creative Commons Attribution License  
(http://creativecommons.org/licenses/by/3.0). This permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction
In men, hypovitaminosis D as well as both high or low testos-
terone levels have been linked to adverse events, including 
death. Vitamin D is a fat-soluble secosteroid hormone endowed 
with pleiotropic effects [1,2].  Besides the well-known function 
of vitamin D in promoting in vitro bone mineralization and 
prevention of osteoporosis and bone fracture through intes-
tinal calcium absorption [3,4], mounting evidence has linked 
hypovitaminosis D to musculoskeletal diseases [5], cancer [6], 
autoimmune diseases, type 2 diabetes, cardiovascular disease 
[6,7] and all-cause mortality [5]. The main source of vitamin D 
is cholecalciferol (vitamin D3), synthesized in the skin by ultra-
violet radiation [2]; pro-vitamin D3 (7-dehydrocholesterol) is 
converted to pre-vitamin D3, which isomerizes into cholecal-
ciferol and is later converted to calcitriol (1,25(OH)2D3) through 
a two-step enzymatic pathway involving liver 25-hydroxylase 
(CYP2R1) andkidney 1-α-hydroxylase (CYP27B1) [2,8,9]. Vitamin 
D status is assessed by measuring 25(OH)D3 [8]. Currently, the 
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Institute of Medicine advises 25(OH)D3 ≥20 ng/ml but Endo-
crine Society advises 25(OH)D3 ≥30 ng/ml, partly due to lack of 
adequate assays for vitamin D quantification; thus, individuals 
are considered sufficient if 25(OH)D3≥30 ng/ml (≥74 nmol/L), 
insufficient if 25(OH)D3 is 20-29 ng/ml (50-74 nmol/L), and 
deficient if 25(OH)D3<20 ng/ml (<50 nmol/L) [5,7]. A bio-
logical interaction has been previously suggested between 
vitamin D and androgens [5,10-12]. Specifically, androgens 
may increase 1-α-hydroxylase, a key enzyme in vitamin D 
metabolism, and regulation of gene expression by vitamin 
D metabolites is modified according to androgen levels [5]. 
Numerous biological mechanisms have been proposed in an 
effort to explain the joint protective effects of vitamin D and 
sex steroids on bone fracture which is generally less among 
males compared to females [12], while other studies have sug-
gested a contribution for testicular vitamin D metabolism [11].
The key androgen, in men,is testosterone, 50-60% of which 
is bound with high affinity to sex hormone binding globulin 
(SHBG), and the remaining 40-50% is bound loosely to albu-
min and other proteins, leaving 1-3% as ‘free’ testosterone 
[13]. The clinical significance of testosterone level in men 
remains controversial [5,14,15], with low and high levels of 
testosterone linked to deleteriousoutcomes [16]. Starting 
in the 3rd-4th decade of life, male aging is accompanied by 
0.4-2.6% annual decline in total testosterone and 0.2% an-
nual decline in ‘free’ testosterone resulting from gradual rise 
in SHBG, implying a clinical significance for measuring‘free’ 
testosterone [5,17,18]. Age-related decline in endogenous 
testosterone, or male hypogonadism, has been associated 
with reduced libido and vitality, depression, sarcopenia, obe-
sity, dyslipidemia, hypertension, metabolic syndrome, type 
2 diabetes, stroke, atherosclerosis, subclinical inflammation, 
osteoporosis, trauma fracture and mortality risk [13,16,19-21]; 
an increasing level of SHBG, which predominantly carries 
testosterone and estradiol in the blood, has also been as-
sociated with cardiovascular risk factors andhigher risk for 
premature death [22]. Similarly, when administered at high 
doses, exogenous testosterone has been correlated with 
sudden cardiac death and liver disease [16,23,24]. However, 
perceived health benefits of low dose exogenous testosterone 
may have contributed to its widespread use without approved 
change in indication [16,22,25-27].
The purpose of this population-based cohort study is to 
simultaneously investigate vitamin D and biomarkers of sex 
steroid hormones (testosterone, estradiol, SHBG as predictors 
of all-cause mortality among adult men in the Third National 
Health and Nutrition Examination Survey (NHANES III).  
Methods
Study population
The National Center for Health Statistics implemented 
NHANES III between 1988 and 1994 in two phases (Phase I: 
1988-1991, Phase II: 1991-1994) using a complex multistage 
probability sample design [28]. This study utilized question-
naire, physical examination and laboratory data from Phase I 
of NHANES III. Public-use datasets, including adult (n=20,050), 
exam (n=31,311), examdr (n=30,818), lab (n=29,314), lab2 
(n=29,314), nhanes3 (n=33,994) and sshormon (n=1,636) 
were merged to select male adults (18 years and older) with 
serum specimens analyzed for vitamin D, biomarkers of sex 
steroid hormones and all-cause mortality data. A total of 1,472 
NHANES III participants were included in the study.  NHANES 
III is compliant with ethical rules of human experimentation 
stated in the Declaration of Helsinki, including approval by 
institutional review board and informed consent.  
Measures
All-cause mortality
Mortality linkage of NHANES III with the National Death Index 
provides the opportunity to investigate associations of a wide 
range of characteristics at baseline with mortality rates at 
follow-up through December 31, 2006. Variables provided 
in this linked mortality file include sequence number, eligi-
bility status, assigned vital status, mortality source, person-
months of follow-up from interview date, person-months of 
follow-up from Mobile Examination Center (MEC) or home 
examination date and underlying multiple causes of death 
[29]. In this analysis, an event was defined as death from any 
cause during the follow-up period, starting at date of MEC 
examination and ending before December 31, 2006. Sensitiv-
ity analyses were performed to examine shorter durations (5 
years and 10 years) of follow-up, yielding similar results to the 
total follow-up period.
Vitamin D
Serum 25(OH)D3 concentration was determined in ng/mL 
(range: 5-160.3 ng/mL; limit of detection is 3.5 ng/mL) and 
nmol/L (range: 12.5-400.1 nmol/L; limit of detection is 8.7 
nmol/L) at the National Center for Environmental health us-
ing DiaSorin radioimmunoassay kit (Stillwater, MN) [30,31]. 
NHANES documentation did not include inter- or intra-assay 
coefficients of variation for vitamin D. Because of skewed 
distribution, vitamin D concentration was loge-transformed 
or defined as a categorical variable (Deficient: <20 ng/ml; 
Insufficient: 20-<30 ng/ml; Sufficient: ≥30 ng/ml), taking the 
sufficient group as a referent.
Biomarkers of sex steroids
Serum testosterone, estradiol and SHBG concentrations were 
quantitatively determined using immunoassay techniques. 
NHANES documentation did not include inter-assay and 
intra-assay coefficients of variation for sex steroid hormones. 
Because of skewed distributions, loge-transformation and 
categorization in quintiles were performed for biomarkers 
of sex steroid hormones.  
Testosterone 
Elecsys Testosterone was used to measure circulating testos-




terone concentration and was based on a competitive test 
principle using a monoclonal antibody directed against tes-
tosterone. The measuring range for testosterone is 0.069-52.00 
nmol/L or 0.020-15.00 ng/mL, with a lower detection limit of 
0.069 nmol/L (0.02 ng/mL) and a functional sensitivity (level 
at which between-run coefficient of variation is less than or 
equal to 20%) of 0.42 nmol/L (0.12 ng/mL) [32]. 
Estradiol
Elecsys Estradiol II was used to measure circulating estradiol 
concentration and employs a competitive test principle using a 
polyclonal antibody specifically directed against 17β-estradiol. 
The measuring range for estradiol is 18.4-15,781 pmol/L (5.00-
4,300 pg/mL), with a lower detection limit of 18.4 pmol/L (5.0 
pg/mL) and a functional sensitivity (level at which between-
run coefficient of variation is less than or equal to 20%) of 44 
pmol/L (12 pg/mL) [33].
Sex hormone binding globulin
Elecsys SHBG is used to measure SHBG concentration and 
employs two monoclonal antibodies specifically directed 
against it. The measuring range for SHBG is 0.350-200 nmol/L, 
with a lower detection limit of 0.35 nmol/L [34].
Demographic, socioeconomic, lifestyle and clinical 
characteristics 
Age (continuous; ‘18-20’, ‘20-39’, ‘40-59’, ‘60+’ years), education 
(‘Less than High School’, ‘High School’, ‘More than High School’), 
race/ethnicity (‘Non-Hispanic White’, ‘Non-Hispanic Black’, 
‘Hispanic’, ‘Other’), area of residence (‘Metropolitan’, ‘Other’), 
poverty income ratio (continuous; ‘<100%’, ‘100%-<200%’, 
‘≥200%’), marital status (‘Married/Co-habiting’, ‘Not married’), 
smoking status (‘Current smoker’, ‘Ex-smoker’, ‘Never smoker’), 
alcohol consumption (at least 12 glasses in the past 12 months) 
(‘yes’, ‘no’), body mass index (BMI) based on directly measured 
weight and height (continuous; ‘<25’, ’25-<30’, ‘30+’ kg/m2), 
waist-to-hip ratio defined as ratio of directly measured waist 
and hip circumferences (continuous; ‘≤0.9’, ‘>0.9’), self-rated 
health (‘excellent’, ‘very good’, ‘good’, ‘fair’, ‘poor’), history of 
chronic conditions including arthritis, asthma, chronic bron-
chitis, emphysema, congestive heart failure, stroke, diabetes 
and cancer (‘yes’, ‘no’), and physical activity (continuous; ‘0’, 
‘>0-<100 METS’, ‘100-<200 METS’, ‘200-<300 METS’, ‘≥300 METS’).
Statistical analysis
Statistical analyses were performed using STATA version 12 
(STATA Corporation, College Station, TX). Whereas frequencies 
and percentages were computed for categorical variables, for 
continuous variables mean, median, standard deviation (SD), 
standard errors of the mean (SEM) and inter-quartile ranges 
were computed, as appropriate. Shapiro-Wilk’s normality 
test was applied and continuous exposure variables were 
loge-transformed, as needed. One-way ANOVA tests with 
post-hoc comparisons evaluated using Bonferronicorrections 
were used for comparing loge-transformed testosterone, 
estradiol and sex hormone-binding globulin concentra-
tions across vitamin D status groups.Kaplan-Meier curves 
were constructed and log-rank tests were used to examine 
bivariate relationships between exposure variables (defined 
in quintiles) and survival. For multivariable analyses, hazard 
ratios (HR) and their 95% confidence intervals (CI) were cal-
culated using Cox regression models. Fully-adjusted models 
were controlled for age (continuous), race/ethnicity, smok-
ing status, and physical activity (categorical). Furthermore, 
we examined non-linearity by including quadratic terms for 
exposure variables and evaluated the interaction between 
vitamin D status and biomarkers of sex steroid hormones in 
age-adjusted and fully-adjusted models. Several aspects of 
NHANES III design were taken into account in data analyses, 
including sampling weights and complex survey design 
(primary sampling unit (PSU) and strata). Three full-sample 
and four sub-sample weights are available in NHANES III. For 
this analysis, we applied the MECweights with strata and PSU 
based on Phases I of NHANES III (i.e., 3 years). Sampling weights 
were used to correctly estimate population prevalence rates, 
means and other statistics while accounting for differential 
probabilities of selection, non-coverage, non-response and 
over-sampling of sub-populations. Two-sided statistical tests 
were performed at alpha of 0.05.
Results
Table 1 describes baseline demographic, socioeconomic, life-
style and clinical characteristics of study participants. Of 1,472 
men with (mean±SEM) age of (42.1±0.6) years at baseline, 77% 
were non-Hispanic White, 70% were married or cohabiting, 
47% had more than high school education and nearly 10% 
were below the PIR. Whereas 35% were never smokers and 
71% drank alcohol in the past 12 months, 18% were obese, 
71% exhibiting central obesity, 13% reported fair or poor 
self-rated healthand 28% reported having major chronic 
conditions,and physical activity was, on average, 139.3±8.2 
METS. Descriptive statistics for vitamin D and biomarkers of 
sex steroid hormones are also presented in Table 1.
Vitamin D was weakly correlated with biomarkers of sex 
steroid hormones including testosterone (rspearman =0.08), 
estradiol (r spearman=-0.07) and SHBG (r spearman=0.09). When 
loge-transformed testosterone, estradiol and SHBG, were 
compared among vitamin D sufficient, insufficient and defi-
cient men, estradiol levels were significantly higher among 
vitamin D deficient compared to vitamin D sufficient men and 
sex hormone binding globulin level was significantly higher 
in vitamin D sufficient compared to vitamin D insufficient or 
deficient groups (Table 2).
A total of382 men died over a median of192 months with 
an interquartile range of 183 to 202 months of follow-up 
(<5 years:100; 5-<10 years:105; ≥10 years:1,267), for an esti-
mated all-cause mortality rate of 16.7% (95%CI:14.8%-18.8%). 
Kaplan-Meier curves were constructed to examineall-cause 


















Married / Cohabiting 69.6
Not Married 30.4
Education:
Less than High School 23.6
High School 29.2
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History of Major Chronic Conditions *:
Yes 28.4
No 71.6







Vitamin D (ng/ml) Mean±SEM or %
Median [IQR] 26.7 [20.2-34.3]




Median [IQR] 5.4±0.15.15  
[3.97-6.56]
Estradiol (pg/mL):
Median [IQR] 37.2±0.735.4  
[29.5-43.7]
Sex hormone-binding  
globulin (nmol/L):
Median [IQR] 37.9±0.836.1  
[25.9-49.7]
Table 1. Demographic, socioeconomic, lifestyle and 
clinical characteristics in adult men in the study 
sample (n=1472)–Third National Health and Nutrition 
Examination Survey.
* Major chronic conditions include self-reported 
physician diagnosis of arthritis, asthma, chronic 
bronchitis, congestive heart failure, diabetes, 
emphysema, stroke, skin cancer and other cancer.
mortality across quintiles of testosterone, estradiol and SHBG, 
and according to vitamin D status. Log-rank tests suggested 
statistically significant crude differences (P<0.0001) in survival 
according quintiles of testosterone and SHBG, but not ac-
cording to estradiol level or vitamin D status (Figures 1A-1D).
Table 3 presents Cox regression models for circulating vi-
tamin D (loge-transformed and categorical) and biomarkers 
of sex steroid hormones (loge-transformed) as predictors of 
all-cause mortality, while examining linearity and interaction 
effects. Vitamin D deficiency but not insufficiency was signifi-
cantly related to all-cause mortality in age-adjusted but not in 
fully-adjusted models. By contrast, loge-transformed vitamin 
D concentration and biomarkers of sex steroid hormones did 
not exhibit a linear relationship to all-cause mortality rate in 
either age-adjusted or fully-adjusted models. By including 
quadratic terms, we observed an inverse non-linear relationship 
between all-cause mortality rate and levels of testosterone, 
estradiol and vitamin D, in fully-adjusted models. Furthermore, 
there were no significant interaction effects between vitamin 
Continuation of Table 1.




























42.9±21.6 38.1±17.9 39.2±20.3 <0.0001sign
0.003sign 
Table 2. Circulating Biomarkers of Sex Steroid Hormones 
Concentrations among Vitamin D Sufficient, Insufficient and 
Deficient Adult Men in the Study Sample (n=1472)-Third 
National Health and Nutrition Examination Survey.
* P values are determined based on one-way ANOVA tests for 
comparing loge-transformed testosterone, estradiol, sex hormone-
binding globulin concentrations across vitamin D status groups.
D and sex steroid hormones in relation to all-cause mortal-
ity rate. We found no significant interaction effects between 
age group and the selected exposure variables; therefore, no 
stratified analyses were performed according to age group 
(data not shown). 
Discussion
In a population-based cohort study, we examined vitamin 
D and biomarkers of sex steroid hormones–separately and 
simultaneously–as predictors of all-cause mortality among 
adult men, 18 years and older, who participated in NHANES III. 
Significant differences in estradiol and SHBG concentrations 
were found across levels of vitamin D status. In age-adjusted 
but not fully-adjusted models, vitamin D deficiency was posi-
tively linked to all-cause mortality. Loge-transformed levels 
of vitamin D, testosterone and estradiol were non-linearly 
but inversely related to all-cause mortality, independently of 
baseline demographic, socioeconomic, lifestyle and clinical 
characteristics. There were no statistically significant inter-
actions between vitamin D and biomarkers of sex steroid 
hormones in relation to all-cause mortality in age- or fully 
adjusted models.
Previously, Sempos and colleagues who analyzed the 
complete cohort of 15,099 NHANES III participants aged 
≥20 years with 3,784 deaths reported over a 9-year follow-
up period (1991-2000) found a reverse J-shaped association 
between serum vitamin D and all-cause mortality [35]. In 
another study of 1,114 NHANES III participants followed-up 
for a period of 18 years, differences in all-cause mortality 
were noticed between 90th and 10th percentiles of the sex 
hormone levels, including free and bioavailable testosterone 
[36]. Discrepancies between these studies and ours may be 
due to differences in exposure assessment and ability to detect 
Age-Adjusted Fully-Adjusted
Overall HR 95%CI HR 95%CI
Testosterone 1.08 0.82-1.43 0.92 0.70-1.22
Estradiol 1.53 0.87-2.70 1.06 0.61-1.81
Sex hormone binding 
globulin:
1.42 0.79-2.54 1.23 0.70-2.17
Vitamin D-continuous 0.84 0.61-1.17 0.99 0.66-1.48
Vitamin D–categorical:
Sufficient Vitamin D Ref. -- Ref. --
Insufficient Vitamin D 0.97 0.69-1.35 0.92 0.65-1.29
Deficient Vitamin D 1.47 1.04-2.08 1.33 0.88-2.01
Linearity HR 95%CI HR 95%CI
Testosterone 0.89 0.76-1.04 0.79 0.66-0.96
Testosterone2 1.22 1.08-1.40 1.19 1.03-1.38
Estradiol 0.08 0.01-0.54 0.05 0.004-0.76
Estradiol2 1.53 1.13-2.05 1.11 1.09-1.12
Sex hormone binding 
globulin
0.07 0.003-1.63 0.24 0.041-3.89
Sex hormone binding 
globulin2
1.50 0.98-2.31 1.25 0.84-1.86
Vitamin D 0.003 0.0002-0.07 0.01 0.0004-0.29
Vitamin D2 2.33 1.46-3.72 2.00 1.98-3.36
Interactions HR 95%CI HR 95%CI
Testosterone 1.13 0.75-1.71 1.00 0.63-1.61
Insufficient Vitamin D 1.04 0.43-2.54 1.08 0.47-2.52
Deficient Vitamin D 1.67 0.49-2.54 1.79 0.58-5.54
Testosterone*Insufficient 
Vitamin D
0.96 0.51-1.79 0.90 0.48-1.68
Testosterone*Deficient 
Vitamin D
0.91 0.39-2.14 0.80 0.37-1.73
Estradiol 1.94 0.71-5.31 1.53 0.52-4.49










0.66 0.16-2.70 0.50 0.12-2.09
Estradiol*Deficient 
Vitamin D
0.52 0.12-2.33 0.51 0.10-2.56
SHBG 1.41 0.67-2.94 1.26 0.62-2.54
Insufficient Vitamin D 1.21 0.02-75.17 1.20 0.03-43.7
Deficient Vitamin D 0.62 0.017-23.04 0.99 0.05-20.9
SHBG*Insufficient 
Vitamin D
0.95 0.32-2.88 0.94 0.35-2.49
SHBG*Deficient  
Vitamin D
1.26 0.49-3.29 1.09 0.48-2.44
Table 3. Cox proportional hazards models for Circulating 
Vitamin D and Loge-transformed Biomarkers of Sex Steroid 
Hormone Concentrations as predictors of Age-Adjusted and 
Fully-Adjusted All-Cause Mortality Rate among Adult Men in 
the Study Sample (n=1472)–Third National Health and Nutrition 
Examination Survey.
Fully-Adjusted Cox proportional hazards models included age, race/
ethnicity, smoking status and physical activity.




Figure 1. Kaplan-Meir curve for all-cause mortality according to. 




small risk changes among groups. For instance, we defined 
testosterone as loge-transformed variables or in quintiles (tak-
ing the 3rd quintile as a referent) and our sample consisted of 
NHANES III participants with data available on vitamin D and 
biomarkers of sex steroid hormones [35,36].
To our knowledge, this epidemiological study is one of few 
to have simultaneously examined vitamin D, biomarkers of 
sex steroid hormones and all-cause mortality and the first 
to assess these associations using a nationally representa-
tive sample. Our study findings pertaining to vitamin D and 
biomarkers of sex steroid hormones as predictors of all-cause 
mortality are somewhat consistent with two previous studies 
[36,37]. In a large cohort of coronary angiography patients, 
Lerchbaum and colleagues observed that vitamin D and free 
T deficient men experienced the highest risk for all-cause 
mortality even after multivariable adjustment. Moreover, in 
men with vitamin D deficiency, low free T levels were associ-
ated with fatal events, whereas no association of free T with 
fatal events was found in men with vitamin D insufficiency 
or sufficiency [5]. In another study of 782 French men ≥50 
years, Szulc and colleagues identified the lowest quartile of 
vitamin D as predictor of mortality (HR=1.44, 95% CI: 1.03-
2.03); estradiol level predicted mortality after the third year 
(HR=1.21 per 1 SD increase, 95% CI: 1.09-1.35), where by risk 
of death increased per quartiles of estradiol level and was 
higher in third and fourth quartiles compared with the low-
est quartile (HR=1.80, 95% CI: 1.09-2.98 and HR=2.83, 95% CI: 
1.71-4.67); mortality risk was not significantly associated with 
testosterone level [37]. Unlike the present study,no formal 
testing for interaction between vitamin D and biomarkers of 
sex steroid hormones was performed in these studies [36,37].
Whereas the link between vitamin D deficiency and all- 
cause mortality is well-established [38-41], the current 
epidemiological evidence linking endogenous total and 
free testosterone concentrations to mortality risk among 
men remains inconclusive. While total testosterone was 
mostly negatively related to mortality [13,14,16,20,42] with 
one study reporting a non-significant relationship [22], free 
testosterone was positively [22] or negatively [5] related to 
mortality andlimited evidence suggests that SHBG may not 
be related [22] to mortality.
The finding that testosterone levelswere negatively and 




non-linearly related to all-cause mortality in fully-adjusted 
models is in line with the idea that as men age they experience 
a decline in testosterone [17,43], and is in line with another 
study [43]. In a case-cohort study of 495 elderly men (146 with 
ischemic arterial disease (IAD) and 349 controls), a J-shaped 
association was observed between total testosterone and 
IAD risk, whereby HR in the lowest and the highest quintiles 
relative to the second quintile were 2.23 (95% CI: 1.02; 4.88) 
and 3.61 (95% CI: 1.55; 8.45), respectively [43]. A similar J-
shaped relationship was observed between IAD risk and free 
T, whereas SHBG was not significantly related to IAD risk [43].
The absence of a significant relationship between SHBG and 
all-cause mortality may be explained by the complex relation-
ship among factors that determine SHBG level. Whereas the 
process of aging is accompanied by a rise in SHBG level, it is 
also accompanied by a rise in cardiovascular risk factors, such 
as obesity, insulin resistance, type 2 diabetes, hypertension, 
dyslipidemia and inflammation, which, in turn, are negatively 
correlated with SHBG level [17].
Our results should be interpreted with caution and in light of 
several limitations. First, the study design is observational and 
although cohort studies are considered as the gold standard 
in epidemiology, cause-and-effect relationships cannot be 
clearly established. Second, sex steroid hormones are known 
to vary on a diurnal basis, and the use of a single measure-
ment for each of these biomarkers could potentially lead to 
non-differential misclassification bias. In addition, sex steroid 
hormones were measured by immunoassays and vitamin D 
was measured using DiaSorin(rather than mass spectrom-
etry) which are now widely understood to be suboptimal for 
clinical research involving women, children or men with low 
serum testosterone [44,45] and especially for serum estradiol 
in men [46,47]. However, previous studies have indicated an 
association between testosterone levels and adverse events, 
irrespective of whether immunoassays or mass-spectrometry 
measurements were applied [5,14,15]. Third, the present study 
examined testosterone and SHBG levels but did not examine 
measures of free or bioavailable testosterone.Further analyses 
should be performed whereby ‘free’ testosterone is calculated 
using validated equations [48,49]. Fourth, sample size limita-
tions may have precluded our ability to identify significant 
interactions between vitamin D and biomarkers of sex steroid 
hormones. Also, complete-subject analyses based on avail-
ability of data on key variables of interest may have resulted 
in selection bias. Fifth, the role of chance cannot be ruled out 
given the large number of statistical tests being conducted. 
Sixth, although numerous covariates were included in the 
multivariate models, residual confounding cannot be ruled 
out as an explanation for the observed associations. For in-
stance, total caloric intake was measured using 24-hour recall 
which may be inadequate as an assessment of usual food 
consumption. Finally, our findings can only be generalized 
to adult men, and further research is needed to evaluate the 
role of sex steroid hormones in women as well as individuals 
at different stages of life. 
Conclusion
Vitamin D, testosterone and estradiol, but not sex hormone 
binding globulin, may be inversely and non-linearly related 
to all-cause mortality among adult men, after adjustment 
for baseline characteristics. Future studies should attempt to 
elucidate the complex relationships of circulating vitamin D 
with sex steroid hormones and their impact on health-related 
outcomesamong men. In particular, studies should assess the 
potentially mediating role of vitamin D in the relationship 
between circulating sex steroid hormones and age-adjusted 
mortality as well as the potentially mediating role of cardio-
metabolic risk factors on the relationship between vitamin 
D and all-cause mortality.




IAD: Ischemic arterial disease 
HR: Hazard Ratio
NHANES: National Health and Nutrition Examination Survey
PSU: Primary sampling unit 
SEM: Standard errors of the mean 
SHBG: Sex Hormone Binding Globulin
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